West Virginia Attorney General Patrick Morrisey said the state will receive more than $153,000 in a national settlement with a prescription drug manufacturer.
Morrisey says in a news release last month that every state and the District of Columbia are participating in the $13.5 million settlement with Boehringer Ingelheim Pharmaceuticals Inc.
The settlement resolves allegations that the company misrepresented the effectiveness of four drugs in treating or managing certain health conditions, including heart attacks, congestive heart failure and chronic obstructive pulmonary disease. The drugs are Micardis, Aggrenox, Atrovent and Combivent.
Topics Virginia
Was this article valuable?
Here are more articles you may enjoy.
Viewpoint: Who Gets Credit for Successful Renewal During Soft Reinsurance Market? 
Zurich CEO Says Staff Let Go as Regulator Finma Imposes Partial Sales Ban 
Brown & Brown Estimates Cost of Howden-Driven Talent War Could Hit $60M in 2026 
Jury Awards 78-Year-Old Victim $56 Million for Crash Caused by Amazon Delivery Driver 
